Clinical Trials · NCT07531251
Clinical Trial in Patients With Barth Syndrome- 4TAZPower
- Phase
- Phase 4
- Recruitment status
- Recruiting
- Sponsor
- Stealth BioTherapeutics Inc.
- Enrollment
- 48
- Start date
- Jul 2026
- Locations
- 3 sites, 3 countries
- Primary endpoint
- Primary Efficacy End Point